Home / Market News / $MRNA
benzinga Market Technicals Impact 65/100 ● neutral

Reported Earlier, Moderna To Replace Warner Bros. Discovery In Nasdaq-100 Index Before Market Open On October 9, 2026

Oct 2, 2026, 6:24 AM UTC · Primary ticker $MRNA

Moderna's inclusion in the Nasdaq-100 is a positive technical catalyst, likely leading to increased institutional buying. Conversely, Warner Bros. Discovery's exclusion will trigger forced selling by index-tracking funds, creating short-term downward pressure.

This headline signifies a significant technical rebalancing within the Nasdaq-100 index. Moderna (MRNA) will experience a boost from passive index funds that are mandated to hold its shares, potentially leading to a short-term price increase. Conversely, Warner Bros. Discovery (WBD) will face selling pressure as these same funds divest their holdings. While the overall market impact on the Nasdaq-100 (QQQ) will be minimal as it's a zero-sum rebalance, the individual stock movements can be pronounced. Traders should monitor volume leading up to October 9, 2026, for potential arbitrage opportunities or short-term directional plays.

$MRNA positive Index inclusion, forced buying
$WBD negative Index exclusion, forced selling
$QQQ neutral Index rebalancing, minor impact
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.